Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Linn

Showing results (301-310 of 430) with videos related to

Pageof 43
Sort By:
International Journal of Cancer|February 13, 2019
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA studyIrene E G van Hellemond, Carolien H Smorenburg, Petronella G M Peer, et al.
Molecular Oncology|March 16, 2015
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced diseaseMaurice P H M Jansen, Leen Sas, Anieta M Sieuwerts, et al.
JAMA Oncology|January 31, 2020
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical TrialTessa G Steenbruggen, Lars C Steggink, Caroline M Seynaeve, et al.
International Journal of Cancer|December 28, 2018
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failureIrene E G van Hellemond, Ingeborg J H Vriens, Petronella G M Peer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer PatientsRichard D Baird, Annelot G J van Rossum, Mafalda Oliveira, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2017
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 yearsEllen G Engelhardt, Alexandra J van den Broek, Sabine C Linn, et al.
Journal of the National Cancer Institute|July 3, 2025
Breast implant illness after reconstruction with silicone breast implantsJonathan Spoor, Marc A M Mureau, Renaud L M Tissier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 23, 2023
Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trialV M Wintraecken, L J Boersma, L M van Roozendaal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
Ovarian Cancer-Specific <i>BRCA</i>-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 TrialPhilip C Schouten, Lisa Richters, Daniel J Vis, et al.
The Lancet. Oncology|November 29, 2007
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)Jolien M Bueno-de-Mesquita, Wim H van Harten, Valesca P Retel, et al.
Pageof 43

Showing results (301-310 of 430) with videos related to

Sort By:
Pageof 43
International Journal of Cancer|February 13, 2019
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA studyIrene E G van Hellemond, Carolien H Smorenburg, Petronella G M Peer, et al.
Molecular Oncology|March 16, 2015
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced diseaseMaurice P H M Jansen, Leen Sas, Anieta M Sieuwerts, et al.
JAMA Oncology|January 31, 2020
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical TrialTessa G Steenbruggen, Lars C Steggink, Caroline M Seynaeve, et al.
International Journal of Cancer|December 28, 2018
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failureIrene E G van Hellemond, Ingeborg J H Vriens, Petronella G M Peer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer PatientsRichard D Baird, Annelot G J van Rossum, Mafalda Oliveira, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2017
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 yearsEllen G Engelhardt, Alexandra J van den Broek, Sabine C Linn, et al.
Journal of the National Cancer Institute|July 3, 2025
Breast implant illness after reconstruction with silicone breast implantsJonathan Spoor, Marc A M Mureau, Renaud L M Tissier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 23, 2023
Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trialV M Wintraecken, L J Boersma, L M van Roozendaal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
Ovarian Cancer-Specific <i>BRCA</i>-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 TrialPhilip C Schouten, Lisa Richters, Daniel J Vis, et al.
The Lancet. Oncology|November 29, 2007
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)Jolien M Bueno-de-Mesquita, Wim H van Harten, Valesca P Retel, et al.
Pageof 43